FLIP Antikörper (AA 31-184)
Kurzübersicht für FLIP Antikörper (AA 31-184) (ABIN7568464)
Target
Alle FLIP (CFLAR) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 31-184
-
Verwendungszweck
- Anti-Human FLIP/CFLAR Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human FLIP/CFLAR (Asp31-Asn184).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- FLIP (CFLAR) (CASP8 and FADD-Like Apoptosis Regulator (CFLAR))
-
Andere Bezeichnung
- FLIP
-
Hintergrund
- CLARP, Inhibitor of FLICE, Casper, CASP8 and FADD-like apoptosis regulator, Caspase homolog, I-FLICE, MRIT, CASP8AP1, CFLAR, Cellular FLICE-like inhibitory protein, Caspase-like apoptosis regulatory protein, c-FLIP, MACH-related inducer of toxicity, Usurpin, FADD-like antiapoptotic molecule 1, CASH, FLAME-1, Caspase-eight-related protein
-
UniProt
- O15519
-
Pathways
- Apoptose, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Target
-